Generalized morphea treated with secukinumab.
Filoni A, Bonamonte D, Civino A, LA Torre F, Congedo M.
Ital J Dermatol Venerol. 2023 Aug;158(4):368-369. doi: 10.23736/S2784-8671.23.07502-3.
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.
Antoñanzas J, Rodríguez-Garijo N, Estenaga Á, Morelló-Vicente A, España A, Aguado L.
Dermatol Ther. 2022 Sep;35(9):e15709. doi: 10.1111/dth.15709. Epub 2022 Jul 20.
Morphea and Eosinophilic Fasciitis: An Update.
Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ.
Am J Clin Dermatol. 2017 Aug;18(4):491-512. doi: 10.1007/s40257-017-0269-x.
Generalized morphea after COVID-19 vaccines: a case series.
Paolino G, Campochiaro C, Di Nicola MR, Mercuri SR, Rizzo N, Dagna L, Rongioletti F, De Luca G.
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e680-e682. doi: 10.1111/jdv.18249. Epub 2022 May 31.
Generalized morphea.
Strober BE.
Dermatol Online J. 2003 Oct;9(4):24.
Adult-onset generalized morphea associated with osteomyelitis.
Chihara M, Asahina A, Yanaba K.
J Dermatol. 2020 Dec;47(12):e446-e447. doi: 10.1111/1346-8138.15568. Epub 2020 Sep 3.
Update on the classification and treatment of localized scleroderma.
Bielsa Marsol I.
Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13.
RF - Generalized Morphea: Definition and Associations.
García-Vázquez A, Guillen-Climent S, Ramón Quiles MD.
Actas Dermosifiliogr (Engl Ed). 2021 Apr;112(4):366-367. doi: 10.1016/j.ad.2019.05.021. Epub 2020 Nov 20.
Deep morphea.
Bielsa I, Ariza A.
Semin Cutan Med Surg. 2007 Jun;26(2):90-5. doi: 10.1016/j.sder.2007.02.005.
Response of recalcitrant generalized morphea to intravenous immunoglobulins (IVIg): three cases and a review of the literature.
Kromer C, Mitterlechner L, Langer N, Schön MP, Mössner R.
Eur J Dermatol. 2021 Dec 1;31(6):822-829. doi: 10.1684/ejd.2021.4173.
